Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02187185 · ClinicalTrials.gov registry record · NA

Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease

A NA study of Inflammation and Periodontitis, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT02187185: Completed NA study of Inflammation and Periodontitis, sponsored by University of North Carolina, Chapel Hill.

NCT02187185 is a NA study of Inflammation and Periodontitis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 175 participants, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02187185, a NA study of Inflammation and Periodontitis, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

This research study has 2 aims. One aim is to see if saliva testing can show if a person has healthy gum tissue, gingivitis, or one of three degrees of periodontitis - mild, moderate, or severe. The second aim is to examine the effect of the Sonicare Elite/Flexcare toothbrush on periodontitis.

Interventions

  • OTHER Sonicare/Elite-Flexcare Toothbrush
  • OTHER Manual Toothbrush

Study Locations (1)

North Carolina

  • The University of North Carolina at Chapel Hill School of Dentistry - Chapel Hill

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2009-04
Est. Completion 2012-03
Phase NA

What the finished NCT02187185 record still lists

NCT02187185 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (39% lower).

The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Sonicare/Elite-Flexcare Toothbrush is the first listed.

NCT02187185 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02187185 about?

NCT02187185 is a clinical study titled "Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease". This research study has 2 aims. One aim is to see if saliva testing can show if a person has healthy gum tissue, gingivitis, or one of three degrees of periodontitis - mild, moderate, or severe. The second aim is to examine the effect of the Sonicare Elite/Flexcare toothbrush on periodontitis.

What is the current status of trial NCT02187185?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2009-04. Estimated completion is 2012-03.

What conditions does trial NCT02187185 study?

This clinical trial studies the following conditions: Inflammation, Periodontitis.

What interventions are being tested in trial NCT02187185?

The interventions under investigation include: Sonicare/Elite-Flexcare Toothbrush (OTHER), Manual Toothbrush (OTHER).

Who is sponsoring clinical trial NCT02187185?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02187185 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02187185's enrollment target sits among peer trials

175 33rd of 132 higher than 100 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02187185, the US trial registry maintained by the National Library of Medicine. NCT02187185 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.